Clinical value of neuroimaging in the diagnosis of dementia. Sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer's disease

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 3, 1999, Pages 119-130

  Silverman, Daniel H S ^a   Small, Gary W ^a   Phelps, Michael E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's Disease; Dementia; FDG; Fluorodeoxyglucose; MRI; Neuroimaging; PET; Positron Emission Tomography; Quantitative MRI; SPECT

Indexed keywords

EID: 0000087029     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00020-5     Document Type: Review

References (68)

1. D.L. Bachman P.A. Wolf R.T. Linn Incidence of dementia and probable Alzheimer's disease in a general population The Framingham study Neurology 43 1993 515 519
2. A.F. Jorm The epidemiology of Alzheimer's disease and related disorders 1990 Chapman & Hall London
3. K. Ritchie D. Kildea Is senile dementia “age related” or “aging related?” Evidence from a meta-analysis of dementia prevalence in the oldest old Lancet 346 1995 931 934
4. G.W. Small P.V. Rabins P.P. Barry Diagnosis and treatment of Alzheimer disease and related disorders Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society JAMA 278 1997 1363 1371
5. D.A. Evans Estimated prevalence of Alzheimer's disease in the US Milbank Q. 68 1990 267 289
6. D. Cohen C. Eisdorfer Depression in family members caring for a relative with Alzheimer's disease J. Am. Geriatr. Soc. 36 1988 885 889
7. D. Gallagher J. Rose P. Rivera S. Lovett L.W. Thompson Prevalence of depression in family caregivers Gerontologist 29 1989 449 456
8. National Institute on Aging. Progress report on Alzheimer's disease 1996. Bethesda: National Institute on Aging; NIH Publication No. 96–4137; 1996.
9. R.L. Ernst J.W. Hay The U.S. economic and social costs of Alzheimer's disease revisited Am. J. Pub. Health 84 1994 1261 1264
10. D.P. Devanand D.M. Jacobs M.X. Tang The course of psychopathologic features in mild to moderate Alzheimer disease Arch. Gen. Psychiatry 54 1997 257 263
11. L.P. Gwyther P.V. Rabins Practical approaches for treating behavioral symptoms of people with mild to moderate Alzheimer's disease Primary Psychiatr. 3 1996 27 38
12. D.H. Ryan Misdiagnosis in dementia Comparisons of diagnostic error rate and range of hospital investigation according to medical specialty Int. J. Geriatr. Psychiatry 9 1994 141 147
13. G.W. Ross R.D. Abbott H. Petrovich Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study JAMA 277 1997 800 805
14. J.R. McCartney L.M. Palmateer Assessment of cognitive deficit in geriatric patients A study of physician behavior J. Am. Geriatr. Soc. 33 1985 467 471
15. P.S. German S. Shapiro E.A. Skinner Detection and management of mental health problems of older patients by primary care providers JAMA 257 1987 489 493
16. A. Mant E.A. Eyland D.C. Pond N.A. Saunders A.H. Chancellor Recognition of dementia in general practice Comparison of general practitioners' opinions with assessments using the Mini-Mental State Examination and Blessed dementia rating scale Fam. Pract. 5 1988 184 188
17. C.M. Callahan H.C. Hendrie W.M. Tierney Documentation and evaluation of cognitive impairment in elderly primary care patients Ann. Intern. Med. 122 1995 422 429
18. L.D. McDaniel T. Lukovits K.D. McDaniel Alzheimer's disease The problem of incorrect clinical diagnosis J. Geriatr. Psychiatry Neurol. 6 1993 230 234
19. R.S. Hoffman Diagnostic errors in the evaluation of behavioral disorders JAMA 248 1982 964 967
20. G. McKhann D. Drachman M. Folstein R. Katzman D. Price E.M. Stadlan Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 34 1984 939 944
21. M.J. Knapp D.S. Knopman P.R. Solomon W.W. Pendlebury C.S. Davis S.I. Gracon A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group JAMA 271 1994 985 991
22. S.L. Rogers L.T. Friedhof The efficacy and safety of donepezil in patients with Alzheimer's disease Results of a US multicentre, randomized, double-blind, placebo-controlled trial Dementia 7 1996 293 303
23. D. Knopman L.S. Schneider K. Davis Long-term tacrine (Cognex) treatment effects on nursing home placement and mortality. The Tacrine Study Group Neurology 47 1996 166 177
24. G.W. Small J.A. Donohue R.L. Brooks An economic evaluation of donepezil in the treatment of Alzheimer's disease Clin. Ther. 20 1998 838 850
25. J.C. Morris P.A. Cyrus J. Orazem Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease Neurology 50 1998 1222 1230
26. M. Sano C. Ernesto R.G. Thomas A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease N. Engl. J. Med. 336 1997 1216 1222
27. M.S. Mittelman S.H. Ferris E. Shulman G. Steinberg B. Levin A family intervention to delay nursing home placement of patients with Alzheimer's disease. A randomized, controlled trial JAMA 276 1996 1725 1731
28. H. Braak E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
29. G.W. Small J.C. Mazziotta M.T. Collins Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease JAMA 273 1995 942 947
30. E.M. Reiman R.J. Caselli L.S. Yun K. Chen D. Bandy S. Minoshima Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E N. Engl. J. Med. 334 1996 752 758
31. J.C. Morris M. Storandt D.W. McKeel Cerebral amyloid deposition and diffuse plaques in “ normal” aging Evidence for presymptomatic and very mild Alzheimer's disease Neurology 46 1996 707 719
32. P. Scheltens F. Pasquier J.G.E. Weerts F. Barkhof D. Leys Qualitative assessment of cerebral atrophy on MRI Inter- and intra-observer reproducibility in dementia and normal aging Eur. Neurol. 37 1997 95 99
33. P. Scheltens L.J. Launer F. Barkhof H.C. Weinstein W.A. Van Gool Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging Inter-observer reliability J. Neurol. 242 1995 557 560
34. C. DeCarli J.A. Kaye B. Horwitz S. Rapoport Critical analysis of the use of computer-assisted transverse axial tomography to study human brain aging and dementia of the Alzheimer type Neurology 40 1990 872 883
35. J.T. O'Brien P. Desmond D. Ames I. Schweitzer E. Chiu B. Tress Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal aging, depression, vascular dementia and other causes of cognitive impairment Psychol. Med. 27 1997 1267 1275
36. E. Pucci N. Belardinelli L. Regnicolo Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease Eur. Neurol. 39 1998 16 25
37. C.R. Jack Jr.; Petersen, R.C.; Xu, Y.C.; et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease Neurology 49 1997 786 794
38. S. Lehericy M. Baulac J. Chiras Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease Am. Soc. Neuroradiol. 15 1994 929 937
39. K. Herholz FDG PET and differential diagnosis of dementia Alzheim. Dis. Assoc. Disord. 9 1995 6 16
40. R. Mielke W.D. Heiss Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia J. Neural. Transm. 53 suppl 1998 237 250
41. J.C. Mazziotta R.S.J. Frackowiak M.E. Phelps The use of positron emission tomography in the clinical assessment of dementia Sem. Nucl. Med. 22 1992 233 246
42. R. Duara C. Grady J. Haxby Positron emission tomography in Alzheimer's disease Neurology 36 1986 879 887
43. S.J. Kippenhan W.W. Barker S. Pascal J. Nagel R. Duara Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects J. Nucl. Med. 33 1992 1459 1467
44. W.J. Powers J.S. Perlmutter T.O. Videen Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease Neurology 42 1992 765 770
45. R. Mielke U. Pietrzyk A. Jacobs HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia Comparison of perfusion and metabolic pattern Eur. J. Nucl. Med. 21 1994 1052 1060
46. C. Messa D. Perani G. Lucignani High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease Comparison with fluorine-18-FDG PET J. Nucl. Med. 35 1994 210 216
47. K.A. Johnson K. Jones B.L. Holman Preclinical prediction of Alzheimer's disease using SPECT Neurology 50 1998 1563 1571
48. Silverman, D.H.S.; Chang, C.Y.; Cummings, J.L.; et al. Prognostic value of regional brain metabolism in evaluation of dementia: Comparison with long-term clinical outcome. J. Nucl. Med. 40:5(Suppl); 1999 (abstract).
49. N. Schuff D. Amend F. Ezekiel Changes of hippocampal N -acetyl aspartate and volume in Alzheimer's disease Neurology 49 1997 1513 1521
50. H. Hanyu H. Shindo D. Kakizaki K. Abe T. Iwamoto M. Takasaki Increased water diffusion in cerebral white matter in Alzheimer's disease Gerontology 43 1997 343 351
51. M.E. Phelps S.R. Cherry The changing design of positron imaging systems Clin. Posit. Imaging 1 1998 31 45
52. E. Salmon B. Sadzot P. Maquet Differential diagnosis of Alzheimer's disease with PET J. Nucl. Med. 35 1994 391 398
53. S. Minoshima B. Giordani S. Berent K. Frey N.L. Foster D.W. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann. Neurol. 42 1997 85 94
54. D.E. Kuhl G.W. Small W.H. Riege Cerebral metabolic patterns before the diagnosis of probable Alzheimer's disease J. Cereb. Blood Flow Metab. 7 Suppl 1 1987 406 S–
55. G.W. Small A. La Rue S. Komo A. Kaplan M.A. Mandelkern Predictors of cognitive change in middle-aged and older adults with memory loss Am. J. Psychiatry 152 1995 1757 1764
56. K. Ishii M. Sasaki S. Yamaji S. Sakamoto H. Kitagaki E. Mori Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease J. Nucl. Med. 39 1998 293 298
57. K. Ishii S. Sakmoto M. Sasaki Cerebral glucose metabolism in patients with frontotemporal dementia J. Nucl. Med. 39 1998 1875 1878
58. A.M. Kennedy R.S.J. Frackowiak S.K. Newman Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzhiemer's disease Neurosci. Lett. 186 1995 17 20
59. Silverman, D.H.S.; Ercoli, L.M.; Komo, S.; Huang, S.-C.; Phelps, M.E.; Small, G.W. Influence of single apolipoprotein E type 4 allele on regional brain metabolism of healthy subjects. J. Nucl. Med. 40:5(Suppl); 1999 (abstract).
60. Small, G.W.; Ercoli, L.M.; Huang, S.-C.; et al. PET and genetic risk for Alzheimer disease. J. Nucl. Med. 40:5(Suppl); 1999 (abstract).
61. T. Vander Borght S. Minoshima B. Giordani Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity J. Nucl. Med. 38 1997 797 802
62. T. Imamura K. Ishii M. Sasaki Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease A comparative study using positron emission tomography Neurosci. Lett. 235 1997 49 52
63. E. Tedeschi S.G. Hasselbach G. Waldemar Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus J. Neurol. Neurosurg. Psychiatry 59 1995 608 615
64. R. Mielke R. Schröder G.R. Fink J. Kessler K. Herholz W.D. Heiss Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease Acta Neuropathol. 91 1996 174 179
65. P. Molsa L. Parjavi J. Rinne U. Rinne E. Sako Validity of clinical diagnosis in dementia A prospective clinicopathological study J. Neurol. Neurosurg. Psychiatry 48 1985 1085 1090
66. J.C. Morris D.W. McKell M. Storandt Very mild Alzheimer's disease Informant-based clinical, psychometric, and pathologic distinction from normal aging Neurology 41 1991 469 478
67. J.P. Wade T.R. Mirsen V.C. Hachinski M. Fisman C. Lau H. Merskey The clinical diagnosis of Alzheimer's disease Arch. Neurol. 44 1987 24 29
68. F. Boller O.L. Lopez J. Moossy Diagnosis of dementia clinicopathologic correlations Neurology 39 1989 76 79